| |
|
AMAA Policy Changes
AMAA Board of Directors Modifies
Genetic Abnormality Guidelines
To better encompass lethal genetic
abnormalities which are identifiable
with a DNA marker and likely to have a
presence in the AMAA data base, the
following guidelines, testing
requirements and registry eligibilities
have been accepted, effective
September 1,
2009.
-
Guidelines:
a) Males
and females will be registered with
“free” status if so tested or designated
free by parentage.
b) Males
and females will be registered with
“carrier” status if so tested.
c) All
other males and females will be registered
with “suspect” status.
d) Status
can be changed at anytime with either a test
of an individual or parentage.
-
Required testing:
a) 25
most used sires will be tested annually
for “all” known lethal genetic
abnormalities at the cost of AMAA.
b) All
other sires and donor dams will be tested
for PHA & TH at the cost of the owner of
record.
-
At the current time no restrictions will
be placed on registry due to status as
long as guidelines and required testing
has been done.
-
If any new genetic abnormality is
discovered in the Maine-Anjou data base
by AMAA’s 25 Most Used Sire Testing
Program, that genetic abnormality will
be added to the required test protocol
for A-I sires and donor dams which are
descendents of positive sire. In
addition all progeny of said positive
sire will be listed suspect for that
genetic abnormality.
03/20/2009
|
|
|